Pilot Study

Summarized by Plex Health
Last Updated: 05 May 2022
sagit®: clinician-reported outcome instrument for managing acromegaly in clinical practice--development and results from a pilot study. "sagit®: clinician-reported outcome instrument for managing acromegaly in clinical practice--development and results from a pilot study.", by Giustina A, Bevan JS, Bronstein MD, Casanueva FF, Chanson P, Petersenn S, Thanh XM, Sert C, Houchard A, Guillemin I, Melmed S, SAGIT Investigator Gro. Fig1: Versions of the SAGIT instrument a used in Step 1 pre-testing (original version) and b following completion of Step 1 pre-testing and Step 2 pilot study...

Heart catheter treatments led by magnetic vibration imaging are as risk-free as X-ray-guided procedures and take say goodbye to time, according to a pilot study conducted at the National Institutes of Health. "It provides proof that clinical heart catheter treatments are possible without using radiation, which can be especially beneficial in areas such as pediatrics. " In general X-ray fluoroscopy pictures have higher resolution however less detail than MRI images. The research team done transfemoral catheterization in 16 patients to check out the right side of the heart, consisting of the attached veins and the pulmonary arteries. The team expected the MRI-guided treatment to take a lot longer because an MRI-compatible catheter can be more challenging to see in an MRI-generated picture than a standard steel catheter can be in an X-ray-generated photo. "Developing safe and obvious catheter devices for MRI is the chief challenge to get over before this technique can be widely used at health centers," claimed study lead Robert J. Lederman, M. D. , a senior detective in the NHLBI's Cardiovascular and Pulmonary Branch. Lederman's research group is still executing MRI catheterization on added patients, and is currently developing boosted catheters and other tools that will be more noticeable under MRI to assist move this modern technology onward. In addition to assisting catheter treatments, the NHLBI team also intends to use MRI to lead non-surgical catheter treatments in the future. Part of the National Institutes of Health, the National Heart, Lung, and Blood Institute prepares, performs, and supports research pertaining to the causes, prevention, medical diagnosis, and therapy of heart, capillary, lung, and blood diseases; and rest disorders.

A pilot study recommends a near real-time technique of imaging prostate cancer to aid in organ-sparing treatments, and an innovative in addition to exact way to see whether the cancer has spread. The radiotracer was lately accepted by the Food and Drug Administration for staging men with prostate cancer as prospects for preliminary conclusive therapy. The two-hour hold-up would enable more time for the radiotracer to affix to cancer cells. The study enlisted 10 volunteers ages 61 to 81 with validated risky prostate cancer. Each was injected with the radiotracer and imaged with dynamic PET imaging over 45 mins and a static PET photo at two hrs after injection. These results indicate that 2 hrs is the optimal delay time for examining localized prostate cancer, although not always excellent for use in routine professional method, the scientists reported. The combination of PSMA-based PET imaging into the regular assessment of prostate cancer has considerably enhanced the exact disease staging, including recognition of metastatic disease, and has improved therapy choices. It is reasonable to mean that PSMA PET might quickly be a part of the regular diagnostic flowchart in many prostate cancer patients for planning primary therapy and perhaps before targeted tumor biopsy, stated Esther Mena, a member of the research team. Adler kept in mind that this is a small pilot study, and added thorough research is required for a more clear-cut evaluation and to verify very early time points for the reliable use PET imaging to keep an eye on therapeutic interventions in real time.

The National Human Genome Research Institute, an essential player in the global Human Genome Project and part of the National Institutes of Health, revealed today the launch of unmatched pilot study to check out the usefulness of massive sequencing of human DNA. "I'm incredibly positive that in three years we'll remain in a placement to pursue the total human sequence in earnest," said Dr. Collins. According to NHGRI's assistant director for program coordination, Dr. Mark Guyer, "The pilot task will assist us figure out whether it will be needed to strive for 99. 99 percent precision when we scale up, and whether it can be done cost effectively with the sequencing strategies arising throughout the following three years. " Given the worth of this info in a host of research setups, particularly for searching for genetics connected to disease, sequence information from the studies will be submitted rapidly into the general public computer system data sources GenBank and Genome Sequence DataBase, and to World Wide Web pages at the task sites. NHGRI is urging the beneficiaries to release preliminary DNA sequence information to the research community within a couple of days or weeks of its exploration. Nevertheless, according to NHGRI, license applications on large blocks of primary human genomic DNA sequence might have a chilling result on the advancement of future innovations of useful items. The hereditary map is used to study how diseases are acquired in families, and the goal was finished when the map included enough spots to be equal to one marker every mile along a road leading from New York to San Francisco. They also assist researchers understand human DNA, because the "model organism" DNA contains information very similar to part of the info in the human genome. The primary detectives and info on private projects, including the buck quantities for the first year of the gives, is supplied: Mark D. Adams, Ph. D. , The Institute for Genomic Research, Rockville, MD: The TIGR group has experience in handling the sequencing of lots of small human DNA fragments and large blocks of microbial genomic DNA. Technology growth will concentrate on effective production and use of DNA "collections" to make the shift from physical maps to DNA series. Richard A. Gibbs, Ph. D. , Baylor College of Medicine, Houston, TX: Human chromosome X contains some regions with a high thickness of genetics and other regions with much lower genetics density. Dr. Gibbs's group is fine-tuning DNA purification and response chemistry techniques, and developing a collection of new fluorescence energy-transfer dyes with the prospective to enhance the accuracy of computerized analysis of DNA bases. Eric S. Lander, Ph. D. , Whitehead Institute for Biomedical Research, Cambridge, MA: In the process of playing a major role in constructing the physical map of the human genome, this group built an incredibly efficient, high-throughput automatic mapping machine and software for automated data analysis. This group, focusing at first on chromosomes 9 and 17, will also develop automation to convert the present physical map to the map required for sequencing. Together they have finished over 37 million bases of the nematode worm, C. elegans, genome. Leveraging this experience in genomic DNA sequencing, Waterston's group will test management structures for large genomic sequencing, focusing originally on areas of human chromosomes 22 and X.

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

** If you believe that content on the Plex is summarised improperly, please, contact us, and we will get rid of it quickly; please, send an email with a brief explanation.

*** If you want us to remove all links leading to your domain from Plex.page and never use your website as a source of the "Online Knowledge", please contact us using a corporate email and we will remove everything in 10 business days.


Plex Page is a Biology & Health Sciences "Online Knowledge Base," where a machine summarizes all the summaries.